Duke Neurosurgery Welcomes New Faculty in July

Two faculty members joined the Department of Neurosurgery in July 2022.

Andrew Cutler

Andrew B. Cutler, MD, specializes in endovascular neurosurgery. His faculty appointment follows neurosurgical residency and an endovascular neurosurgery fellowship at Duke. He received his medical degree with honors at University of Florida, and bachelor's and master’s degrees at Stanford University.

During his residency, Cutler was recognized with several prestigious awards, including the Duke Neurosurgery Leadership Award in 2020, 2021, and 2022; the Duke Neurosurgery Surgical Excellence Award in 2021; and the Graduate Medical Education Snyderman Award in 2020.

Cutler devotes his clinical practice to endovascular care and treatment of neuroendovascular diseases, surgical and endovascular cerebral revascularization, and skull base neurosurgery.

In recent years, his research has focused on the development of a self-contained neuro-navigation system based on the Microsoft HoloLens holographic display system to aid in external ventricular drain placement in the ICU setting. He is also working to further develop Duke Neurosurgery Residency Program’s Surgical Autonomy project, working with program leadership in the continued evolution of a software platform designed to aid resident operative training.


Headshot of Michael Brown

Michael C. Brown, PhD, studies tumor immunology and cancer immunotherapy as a member of the Preston Robert Tisch Brain Tumor Center. His current projects include leveraging childhood vaccines to induce antitumor functions of memory CD4 T cells, engaging intratumor innate immunity with viruses and virus-like features to revive antitumor immunity, and elucidating mechanisms that compromise antitumor immunity in brain tumor patients. 

A North Carolina native, Brown received his bachelor’s degree from UNC Chapel Hill and his PhD from Duke University in 2016. As a postdoctoral fellow at Duke, he was awarded NRSA F32 and K99/R00 grants from the NCI, a grant from the National Cancer Center, and has been continuously funded since 2017. He has authored more than 25 peer-reviewed publications.